Disclosures for "Real-World Retrospective Safety Analysis in Patients Treated with OnabotulinumtoxinA for Multiple Therapeutic Indications over Repeat Treatment Periods"
-
Dr. Forde has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
-
Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for IPSEN. Atul T. Patel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. Atul T. Patel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for IPSEN. The institution of Atul T. Patel has received research support from Abbvie. The institution of Atul T. Patel has received research support from IPSEN.
-
The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. The institution of Dr. Martinez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance. The institution of Dr. Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie/Allergan. The institution of Dr. Martinez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Martinez has received research support from Medtronic. The institution of Dr. Martinez has received research support from Abbvie/Allergan.
-
Dr. Mayadev has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Mayadev has received research support from Ipsen.
-
Dr. Brucker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Dr. Brucker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic . Dr. Brucker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sumitomo pharma . The institution of Dr. Brucker has received research support from Abbvie. The institution of Dr. Brucker has received research support from Sumitomo pharma.
-
Dr. Brown has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astellas. The institution of Dr. Brown has received research support from Merck.
-
Prof. Ayyoub has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Prof. Ayyoub has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Ipsen.
-
Dr. Singh has received personal compensation for serving as an employee of AbbVie. Dr. Singh has stock in AbbVie.
-
Dr. Nelson has received personal compensation for serving as an employee of AbbVie. Dr. Nelson has stock in AbbVie Inc.
-
Ahunna Ukah has received personal compensation for serving as an employee of AbbVie. Ahunna Ukah has stock in AbbVie.
-
Dr. Yushmanova has received personal compensation for serving as an employee of AbbVie.
-
Dr. Battucci has received personal compensation for serving as an employee of AbbVie . Dr. Battucci has stock in AbbVie .
-
Kimberly Ifantides has received personal compensation for serving as an employee of AbbVie. Kimberly Ifantides has stock in Abbvie.
-
Dr. Rhyne has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Rhyne has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie/Allergan. Dr. Rhyne has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie/Allergan. Dr. Rhyne has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck.